ストックスクリーナーアプリを入手
13.94
0.05%
0.0042
前日終値:
$13.94
開ける：
$14.1
24時間の取引高:
1.23M
Relative Volume:
0.77
時価総額：
$1.83B
収益：
$3.34B
当期純損益:
$97.10M
株価収益率:
-23.44
EPS:
-0.595
ネットキャッシュフロー:
$208.00M
1週間 パフォーマンス:
-7.21%
1か月 パフォーマンス:
-14.44%
6か月 パフォーマンス:
-10.25%
1年 パフォーマンス:
-38.99%
1日の値動き範囲:
$13.79
$14.18
1週間の範囲:
$13.52
$14.99
52週間の値動き範囲:
$11.41
$23.79
Surgery Partners Inc Stock (SGRY) Company Profile
名前
Surgery Partners Inc
セクター
電話
615-234-5900
住所
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, EHC, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
13.95 | 1.78B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
429.35 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
277.36 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.39 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.80 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
175.04 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 再開されました | JP Morgan | Neutral |
| 2025-07-28 | 再開されました | BofA Securities | Buy |
| 2024-12-16 | 開始されました | BofA Securities | Buy |
| 2024-10-14 | 開始されました | UBS | Buy |
| 2024-10-11 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | 開始されました | Macquarie | Outperform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-11-14 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-05-12 | 開始されました | Mizuho | Buy |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-11-23 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-06-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-01-10 | 再開されました | Citigroup | Buy |
| 2021-11-30 | 開始されました | Barclays | Overweight |
| 2021-11-29 | アップグレード | Stifel | Hold → Buy |
| 2021-11-01 | 開始されました | JP Morgan | Neutral |
| 2021-10-18 | 開始されました | SVB Leerink | Outperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-06-23 | 再開されました | Stifel | Hold |
| 2020-09-17 | 繰り返されました | The Benchmark Company | Buy |
| 2020-04-27 | アップグレード | The Benchmark Company | Hold → Buy |
| 2020-03-03 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-01-14 | 繰り返されました | The Benchmark Company | Buy |
| 2018-11-16 | 開始されました | UBS | Neutral |
| 2018-09-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | アップグレード | Stifel | Sell → Hold |
| 2018-01-30 | 繰り返されました | The Benchmark Company | Buy |
| 2017-11-01 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | ダウングレード | Stifel | Hold → Sell |
| 2017-04-24 | 繰り返されました | Stifel | Hold |
| 2017-03-10 | ダウングレード | Stifel | Buy → Hold |
| 2017-01-31 | 開始されました | The Benchmark Company | Buy |
| 2016-06-10 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-10-27 | 開始されました | Stifel | Buy |
| 2015-10-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2015-10-26 | 開始されました | Raymond James | Strong Buy |
すべてを表示
Surgery Partners Inc (SGRY) 最新ニュース
Surgery (SGRY) EPS and Revenue: EPS Lands Above Forecast; After Earnings: Shares Move Higher 2.50% on the DayEarnings Stability Report - Vinanet
Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com
Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Canada
Surgery Partners (SGRY) Insider Teresa Deluca Purchases 10,000 S - GuruFocus
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat - Yahoo Finance
Surgery Partners Director Teresa DeLuca Acquires 10,000 Shares at $14.35 Each - Kalkine Media
Surgery Partners Earnings Call Highlights Strategic Reset - TipRanks
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - Sahm
Surgery Partners Beats Q2 Estimates, Divests Idaho Falls Hospitals in Strategic Pivot - finance.biggo.com
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail
Community Health Trades at a Deep Discount to Peers: Hold or Fold? - TradingView
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - Moomoo
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada
TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo
Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat
Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm
Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK
Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus
Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang
SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria
SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus
Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com
Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa
Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com
SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance
Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail
Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - Seeking Alpha
Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media
Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan
Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet
Surgery Partners: Q2 Earnings Snapshot - AOL.com
Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet
SGRY Looks 42.7% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats - Investing.com Nigeria
Surgery Partners Q2 Earnings Call Highlights - MarketBeat
Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Surgery Partners shares edge lower despite Q2 revenue beat - Yahoo Finance
Surgery Partners Announces Q2 and H1 2026 Financial Results with Investor Call - Kalkine Media
Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com Canada
Transcript : Surgery Partners, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Surgery Partners Inc (SGRY) 財務データ
収益
当期純利益
現金流量
EPS
0.99%
1.92%
大文字化:
|
ボリューム (24 時間):